The Medicines & Healthcare products Regulatory Agency (MHRA) has released its Post Referendum Briefing. The briefing, which comes with the subtitle "Business Continues", covers how the agency will address the UK's decision to leave the EU.
The briefing points out that the UK currently remains a full and active member of the EU, and that "the [MHRA] remains fully committed to delivering our workload of EU regulatory procedures and complementing the work of other agencies in delivering the broad range of initiatives and system improvements... Over the long term we will remain totally committed to working alongside our European and global partners in the protection of international public health and patient safety."